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Abstract 24 
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The gut microbiotahasa crucial effect on human health and physiology. Hypothyroid 25 
Hashimoto's thyroiditis(HT) is an autoimmune disorder manifested with environmental 26 
and genetic factors. However, it is hypothesized that intestinal microbes might play avital 27 
role in the pathogenesis of HT. The aim of current study was to investigate and characterize 28 
the gut microbial composition of HT patients both quantitatively and qualitatively. The 29 
fecal samples from 29 HT patients and 12 healthy individuals were collected. The PCR-30 
DGGE targeted V3 siteof 16S rRNA gene and real time PCR for Bifidobacterium 31 
Lactobacillus, Bacteroides vulgatus and Clostridium leptumwereperformed. 32 
Pyrosequencing of 16S rRNA gene with V4 location was performedon 20 randomly 33 
selected samples. The comparative analysis of diversity and richness indices revealed 34 
diversification of gut microbiota in HT as compared to control. The statistical data 35 
elucidate the alterations in phyla of HT patients which was also affirmed at the family level. 36 
We observed the declined abundance ofPrevotella_9 and Dialister, while elevated genera 37 
of the diseased group included Escherichia-Shigella and Parasutterella. The alteration in 38 
gut microbial configuration was also monitored at the species level,which showed an 39 
increased abundance of E.coliin HT. Therefore, the current study is in agreement with the 40 
hypothesis that HT patients have intestinal microbial dysbiosis. The taxa statistics at 41 
species-level along with each gut microbial community were modified in HT. Thus, the 42 
current study may offer the new insights into the treatment of HT patients, disease pathway, 43 
and mechanism. 44 
Keywords: Hashimoto’s thyroiditis, Gut microbiota, Hyporthyroidism, DGGE, 45 
Pyrosequencing 46 
At a glance 47 
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 48 
1. Introduction 49 
The human gut microbiotais a major factor for host health status, and its contribution is 50 
crucial for normal body mechanism, thus considered as vital aspect for influencing the 51 
health grading of an individual [1]. The complexion of the human gut microbiota is quite 52 
diverse with approximately 100 trillion microbes in the body serve as a metabolic, 53 
nutrition, absorption and immune function against pathogens [2]. The abnormality in the 54 
body homeostasis can, in turn, affect the composition pattern of gut microbiota,therefore 55 
resulting in diseases implications[3]. 56 
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HT is specifically organ linked autoimmune disease characterized by thyroid gland chronic 57 
inflammation. The disease was first reported in 1912 by Hakaru Hashimoto and was 58 
referred as autoimmune thyroid deficient disease (AITD).The exact pathogenicity of the 59 
disease still needs to be unraveled under the intense phase of most probable 60 
mechanisms[4]. The disease is now believed to be the autoimmune [5] endocrine disorder 61 
[6] considered as the contributing factor of hypothyroidism [7].  62 
This autoimmune disorder manifested with no unusual clinical symptoms but with the 63 
gradual deterioration of thyroid gland, characterized by goiter, hypothyroidism, weight 64 
gain, constipation, and depression [8]. 65 
The epidemiological data depicted the prevalence of disease frequency eight times higher 66 
in females as compared to males [9]. The most common cause of hypothyroidism is iodine 67 
deficiency[10-12].The body’s innate immune mechanism permits the binding of specific 68 
receptors thus identifying the molecules related to gut bacteria. The specificity of bound 69 
receptors activate the immune response of the host and release the defensive cytokines, 70 
white blood cells and peptides [13]. 71 
The recent molecular studies performed on 250 Chinese HT patients identified that single 72 
nucleotide polymorphism (SNP) in STAT3 gene has an association with HT [14]. The 73 
bacteriocins production by intestinal bacteria competing for nutrients and clinging of gut 74 
lining thus averting any colonization by pathogens [15]. 75 
The modulation in gut floral configuration has been linkedto numerous disease disorders, 76 
including colitis, Crohn’s disease, viral diarrhea, metabolic diseases like obesity, and 77 
diabetes type II [16]. Mori K et al. described the possible relationship between thyroid 78 
autoimmunity and gut with weak evidence having very few studies consolidating such link. 79 
5 
Furthermore, the review emphasizes to validate the hypothesis of gut microbial dysbiosis 80 
in HT with further research[17]. 81 
The current study aim was to estimate the alteration, similarity, and diversity of gut 82 
microbiota quantitatively and qualitatively in HT patients in comparison to healthy 83 
controls. By using PCR-DGGE and sensitive metagenomic pyrosequencing, we have 84 
monitored the gut microbial similarity and diversity in patients suffering from HT disease. 85 
The investigations demonstrated the variation in bacterial taxa richness in contrast to 86 
controls, with some distinct gut microbes depicting significantly higher or lower abundance 87 
against the control. The significance of these alterations in the gut microbiota of HT was 88 
notably high-pitched as never reported before regarding gut microbial characterization in 89 
HT. Current findings thus help to illustrate the overall composition of gut microbiota in 90 
HT patients. 91 
2. Material and methods92 
2.1. Ethics statement 93 
The informed written consent was obtained from all the participants of the study including 94 
diseased patients as well as healthy volunteers. Moreover, the study was approved by an 95 
institutional ethical review committee of Xián Jiaotong University and performed under 96 
the guidelines of the World Medical Association and Declaration of Helsinki. 97 
2.2.Sample collection 98 
Fecal samples from 29 HT patients (20 females and 9 males, aged between 40 to 60 years) 99 
and 12 healthy volunteers (8 females 4 males, aged between 40 to 60 years) were collected 100 
in a sterile cup. The patients with HT were diagnosed according to the standard protocol of 101 
department of endocrinology and metabolic diseases, 1st affiliated hospital, school of 102 
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medicine Xi’an Jiaotong University. It includes goiter, especially the enlargement of the 103 
isthmus, medium hardness of the enlarged thyroid. The Thyroid stimulating 104 
hormone(TSH) was higher than 5μIU/ml, T4 was lower than 4.2 μg/dl, T3 was lower than 105 
0.78 ng/ml, anti-thyroid peroxidase antibodies level was higher than 15 IU/ml, and anti-106 
thyroglobulin antibodies was more than 30%[18]. Normal range of serum thyroid 107 
hormones and antibodies are TSH (0.25-5 μIU/ml), T4 (4.2-13.5μg/dl), T3 (0.78-2.20 108 
ng/ml), Anti-TPOAb (<15 IU/ml) and Anti-TGAb(< 30%).A questionnaire for each 109 
participant was prepared based on the information about gender, age, body weight, health 110 
and dietary habits. All the samples were delivered on ice, usually within 4 hours of 111 
defecation. Upon arrival in the laboratory, the fecal samples were stored at -80ºC until 112 
DNA extraction. Neither of the patients and healthy individuals had any history of 113 
gastrointestinal diseases nor taken antibiotics, probiotics, and prebiotics, 60 days before 114 
sampling.  115 
2.3. DNA extraction from fecal sample  116 
QIAGEN (Hilden, Germany) Stool kit was used for DNA extraction after thawing the fecal 117 
samples, with the first step of bead-beating at 5000 rpm for 30 s. Nano Photometer 118 
(IMPLEN, Germany) was used to estimate the DNA concentration [19]. 119 
2.4. PCR Amplification for DGGE 120 
The fecal bacterial DNA was used for PCR–DGGE. Universal linkage primers table 1was 121 
deployed to augment 16S rRNA gene focusing V3 region. 50 μl PCR reaction mixture was 122 
amplified through PCR touchdown programming by using thermocycler (ABI2720 USA): 123 
final PCR products were electrophoresed on1.5% agarose gel and stained with ethidium 124 
bromide for visualization under UV illumination [20]. 125 
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2.5. Denaturing gradient gel electrophoresis 126 
Denaturing gradient gel electrophoresis was performed by using the DCodeTM Universal 127 
Mutation Detection System (Bio-Rad, Hercules, CA, USA). Briefly, amplified PCR 128 
product from total bacteria was loaded in 8% (w/v)polyacrylamide (acrylamide-bis, 37.5:1) 129 
gels in the1×TAE buffer, containing 30~65 % linear denaturant gradient. The gel was 130 
allowed to run for 14hours at 90V at a constant temperature of 60ºC[21] 131 
2.6.Statistical analysis of DGGE band pattern 132 
Bacterial diversity was estimated by the number of bands and band intensity of DGGE 133 
profiles by applying Syngene software (Bio-Rad, USA). The diversity of taxa was 134 
evaluated by Shannon–Weaver index of diversity(H¹)[22, 23]. Similarity matrix and cluster 135 
analysis of DGGE profiles were computed by using the UPGMA method based on the Dice 136 
similarity coefficient (band-based). Microsoft Excel 2010 and GraphPad 7 prism were 137 
applied, whereas (P<0.05) was considered as statistically significant. Similarities among 138 
the samples were shown through graphical dendrogram (Fig.1.B and Fig.1.D). Clustering 139 
algorithm and (UPGMA) arithmetic averages weredeployed to estimate unweighted pair 140 
group dendrograms [24]. 141 
Shannon Weaver diversity index (H¹) was estimated with the help of the following equation. 142 
Shannon-Weaver index (H¹) =_∑ (𝑃𝑖)(In𝑃𝑖)
𝑠
𝑖=1
 143 
Excision of bands and sequencing 144 
Physically a sterilized scalpel was used to excise the dominant band of interest from the 145 
gel with care. The polyacrylamidegel piece was placed in a 2 ml tube containing50 μlof 146 
water and incubated at 37ºC for 30 min. After centrifugation,8μl of this was used as a 147 
template for PCR re-amplification (targeting V3 region) with the same primers (without 148 
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GC-clamps) as previously used for DGGE analysis[25]. ABI 3500xL was used to 149 
sequencing the reamplified PCR products. Sequences were studied and analyzed by using 150 
BLAST and Seqmatch software for identification of species or genus. 151 
 Real time PCR execution 152 
Real time PCR was performed in Bio-Rad CFX96 (USA) system. Total 20 μl PCR reaction 153 
combination possessed 1 μl of two linkage primer (5 uM), 10 μl 2× SYBR Green 154 
(TOYOBO, Japan), 2 μl sample DNA and 6 μl sterilized H2O[26]. Real time PCR Primers 155 
are shown in (Table 1). Clostridium leptum(YIT.6169), Bacteroides vulgatus NWS 156 
Lactobacillus, (from our lab), (CICC.22938) and Bifidobacteriaum(CICC.6186) were 157 
taken as standard strains. Real time PCR was performed in thrice and mean was calculated. 158 
The outcome data were considered as the estimate of average logarithms in afecal sample 159 
of PCR genomic amplicons, replica counts in 1 g of fecal mass. 160 
2.7.Pyrosequencing and data analysis 161 
Twenty fecal samples were randomly selected for metagenomic pyrosequencing analysis 162 
(10 samples from HT and 10 samples from healthy control). According to a previously 163 
described method, 16S rRNA gene along with V4 location was augmented with linkage 164 
primer: 515F (GTGCCAGCMGCCGCGGTAA) 806R 165 
(GGACTACHVGGGTWTCTAAT) primers to develop the amplicon libraries [27]. The 166 
sequencing along with paired-end was performed on the platform with an Illumina Miseq 167 
based on a standard protocol from the manufacturer. Raw data were screened and 168 
assembled by QIIME [28] and FLASH [29] software packages. The UCLUST method 169 
[28]was applied in clustering the bacterial sequences in OTUs (Operational Taxonomic 170 
Units) at an identity threshold of 97%. Meanwhile, RDP Classifier [30] was applied to allot 171 
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each OTU to a taxonomic level. Diversity analysis, such as Shannon and Simpson diversity 172 
index, Chao1, ACE and Good’s coverage, was carried out with QIIME. In addition, the 173 
OTU table produced by the QIIME pipeline was imported into MEGAN 4 and mapped on 174 
the NCBI taxonomy database [31]. The significant statistical differences of gut microbial 175 
community texture along with Simpson and Shannon index between DNA sample batches 176 
were estimated by computing (unpaired nonparametric t test) Microsoft Excel 2010 and 177 
statistic software GraphPad Prism 7. 178 
3. Results 179 
3.1. Statistical DGGE characterization of bacterial population in HT 180 
The Denaturing Gradient Gel Electrophoresis (DGGE) was deployed with amplified PCR 181 
product targeting 16S rRNA gene along with specific primers at the site of V3 region in 182 
both HT patients and control. The findings in figure 1 panel A (H1–H17), indicate samples 183 
from HT and (C1-C6) healthy control, while figure 1 panel C (H18–H29), with samples 184 
from HT and (C7- C12) healthy control. The band's intensity, location, and number were 185 
diverse among samples indicating diverse intestinal microbial fingerprints. Syngene 186 
software detected the sums of 278 bands in 29 tracks of HT with an average band of (9.2 187 
± 3.75). A total 96 bands were detected in 12 tracks of the control group with an average 188 
of (8.00 ± 2.04).  Stool microbial diversity among patients and normal control group were 189 
analyzed by applying nonparametric unpaired t test to evaluate the (H¹) Shannon Weaver 190 
diversity index. The (H¹) diversity outcomes depicted (2.72 ± 0.621 vs. 2.64 ± 0.45) 191 
insignificant (P = 0.299) gut microbial diversity difference between HT and healthy control 192 
groups. Conversely while comparing the Shannon Weaver index (H¹), it was found to be 193 
higher in HT group in contrast to control group that denoted the bacterial overgrowth in 194 
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the diseased group. The DGGE profiles similarity levels of all samples were determined 195 
by (UPGMA) dendrogram and Dice similarity coefficient (figure 1 panel B, D). The value 196 
of band based assessment along with Dice similarity coefficient in HT and healthy control, 197 
through mean similarity index, were (0.300 ± 0.280) and (0.290 ± 0.121), respectively 198 
shown in (table.2). Comparative statistical samples estimated values in HT and control 199 
groups were evaluated by using Dice similarity coefficient as well as mean similarity index 200 
linking between the two groups. The results indicated the lower level of similarity index in 201 
inter-group in contrast to intra-group that demonstrated the gut microbiota of HT patients 202 
were differentfrom healthy control group.  203 
 204 
 205 
 206 
 207 
 208 
 209 
 210 
 211 
 212 
 213 
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Figure 1., (A) DGGE profile constructed betweenHT (H1-H17) and control groups (C1-216 
C6). (B) Cluster analysis between HT(H1-H17) and control (C1-C6) groups by applying 217 
UPGMA. (C) DGGE profile erected between HT (H18-H29) and control groups (C7-218 
C12).(D) Cluster analysis between HT (H18-H29) and control (C7-C12) groups by 219 
applying UPGMA.“a” and “b”in figure (A) and (C) related to dominant bands from different 220 
patients. H or C represent Hashimoto and control group, respectively.  221 
3.2. Sequence results analysis in DGGE 222 
A total of 18 bands were excised from two DGGE gels. From DGGE gel figure 1panel A, 223 
10 bands were cut for gut bacterial quantity estimation. To endorse the resolution 224 
competence of DGGE genomic bands in the same positions but indifferent lanes (H9a and 225 
H11a) were excised and sequenced. Bands H9a and H11a were identified as Shigella 226 
dysenteriaewith98% similarity. Similarly, from (figure 1 panel C), 8 bands were cut. Also 227 
to check the resolution ability of DGGE gel, bands H25a, H26a were sequenced and 228 
identified as Shigella flexneriwith 99%similarity. Taxonomic identity of other genomic 229 
bands are shown in table.3. The results were demonstrating the phylum Proteobacteria 230 
Firmicutes and Bacteroidetes were prevalent in all samples. The findings of two DGGE gel 231 
profile were also illustrated, the prevalence of opportunistic gut bacteria (Bacteroides 232 
uniformis, Bacteroides pyogenes, Bacteroides vulgates, Shigella dysenteriae, Bacteroides 233 
intestinalis, Escherichia coli, Sporomusa ovate, Bacillus sp., Shigella flexneri)in HT 234 
patients. 235 
3.3. Real time PCR  236 
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By applying real time PCR, Bifidobacterium, Clostridium leptum,Bacteroides vulgatus and 237 
Lactobacillus were quantified, the resultant copy number of Bifidobacterium and 238 
Lactobacillus were significantly (P < 0.05) reduced in the diseased group as compared to 239 
healthy subjects. On the other hand, the replica count of Bacteroides vulgatuselevated non-240 
significantly and Clostridium leptumwas lowered non-significantly in the patients while 241 
comparing to control group, respectively. All these results were summarized in table.4.  242 
3.4. Pyrosequencing analysis of gene sequence 243 
The PCR sequence amplicons comparative statistics were estimated with 1,843,183 at 244 
theV4 site of 16S rRNA gene from 10 HT and 10 from a normal control. Among these sum 245 
of pyrosequencing reads 1,541,154 (control 767,213 and disease 773,941, with an average 246 
per sample 77,058) were passed for quality control and were processed for further analysis. 247 
Taxon tag was (Ave. 72810.35) in all samples of both HT and control group and the total 248 
unique tag count detected in diseased and control group was12241 and10457, respectively 249 
(with Ave. 1134.9 in all samples).The total number of OUT were assigned 5509 (control 250 
2644 and disease 2865, with an average per sample 275.45) in this study. The sum of the 251 
unique tag from the two groups was 22698 that exhibited the whole phylotypes in the 252 
current study, after deletion of linkage primers;the length of the average sequence was 418 253 
bp.   254 
 255 
3.5.Gut microbial diversification and conformational analysis 256 
The richness and diversity of bacterial community were calculated at the 97% similarity 257 
level. Alpha diversities, as estimated by nonparametricalgorithm ACE, Chao1 and 258 
observed species were significantly elevated in HT (P = 0.042,P = 0.039) andP= 259 
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0.045respectively)as comparedto the normal individuals. However, Good's coverage was 260 
significantly higher in control group (P = 0.012). Conversely, there were no statistically 261 
significant differences in Simpson and Shannon diversity index between the two groups. 262 
The degree of diversity estimation in all thesame groups of bacterial community is shown 263 
in table 5. Furthermore, the alpha gut bacterial diversity analysis demonstrates the raised 264 
level in HT patients as compared to control group. The diversity elevation indicates a clear 265 
gut microbial overgrowth in patients group in contrast to healthy control. The bacterial 266 
DNA samples within each group or individual samples were divided into two clusters, 267 
based on weighted UniFrac metrics depicted in figure 2 corresponding to samples of HT 268 
and normal control group analogous to the pattern of PCR-DGGE. 269 
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 270 
Figure 2. Diversity among HT samples of pyrosequencing. UPGMA based on weighted 271 
UniFrac distances.H or C represent Hashimoto and control group, respectively. 272 
 273 
a) Gut microbiota population at phyla level 274 
The gut microbial taxa composed of more than (1%-0.5%) were focused, and composition 275 
was assessed on the taxonomic basis at phylum, family, genus and species level. 276 
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At Phylum level, total 13 phyla were sequenced;depicted intable S1, among the 10 top 277 
most phyla, the more phyla abundance of Proteobacteria and Cyanobacteria and less 278 
Firmicutes and Bacteroidetes in the study group as compared to the normal healthy 279 
controls, shown in figure 3. The data statistics in table6 demonstrated that dissimilarity 280 
was quantitatively different in top 10 phyla between study and control groups.  281 
 282 
Figure 3.Gut microbial composition at phyla levels from Pyrosequencing results. Relative 283 
abundance of most prevalent phyla in HT and healthy control.H or C represent Hashimoto 284 
and control group, respectively 285 
b) Gut microbial organization at family level 286 
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At the family level, 83 different families were sequenced, among 10 top most families, the 287 
prevalence of Bacteroidaceae, Enterobacteriaceae and Alcaligenaceae were higher in the 288 
diseased group as compared to control, shown in figure4. In these families, the relative 289 
abundance of Prevotellacea, Ruminococcaceae, and Veillonellaceae was lowered in 290 
patients group in contrast to healthy control. The family level data statistics with the 291 
percentage in HT illustrates the quantitative difference displayed in table 6. 292 
 293 
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Figure 4. Pyrosequencing results of gut microbial compositions at family levels. Relative 294 
abundance of most dominant families in HT and healthy controls.H or C represent 295 
Hashimoto and control group, respectively 296 
c) Gut microbiota distribution at Genus level  297 
 The genus level sequence represented with 194 different genera. In 10 top most genera, 298 
there was raised anabundance of Bacteroides, Escherichia-Shigella and Parasutterella 299 
genera in the diseased group in contrast to control group shown in figure 5. However, 300 
decreased genera in disease group were Prevotella_9 and Dialister. The Statistics 301 
dissimilarity at genera level in HT group findings were compiled in table 6. 302 
HT has an impact on specific groups of gut microbiota, in particular, the Phylum 303 
Proteobacteria, family Prevotellaceae, Veillonellaceae, generaPrevotella_9, Dialister, and 304 
Escherichia-Shigella and also largely influences the gut flora, which diverges as of the 305 
general normal healthy status based on the intestinal microbial composition of the 306 
individual.  307 
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 308 
Figure 5. Gut microbial compositions at genera levels from Pyrosequencing results. 309 
Relative abundance of most prevalent genera in HT and healthy control.H or C represent 310 
Hashimoto and control group, respectively 311 
d) Gut microbiota distribution at species level 312 
The patterns of gut microbial community monitored at species level shown in table 7. 313 
These findings demonstrate the considerable dissimilarity at species level between HT and 314 
control group.However, E.coli has raised the level in HT patients in comparison to their 315 
healthy controls. 316 
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The concluding data from these findings by applying the metagenomic analysis of DGGE 317 
and pyrosequencing validate the same prevalent bacterial taxa. Nevertheless, the much 318 
reliable and sensitive pyrosequencing procedure affirm the authenticity of enhanced 319 
diversified bacterial population than DGGE. Quantitatively, trend wise metagenomic 320 
pyrosequencing and Real time PCR results ratified each other in the whole bacterial 321 
community. Therefore, in conclusion, the whole result findings were thus aligning the gut 322 
microbiota data produced by the three molecular methods. 323 
4. Discussion 324 
Human gut microbiota plays a critical role inbody protection through metabolic, trophic 325 
and protective function [32]. The gut microbial composition can be altered in disease 326 
conditions like Crohn’s disease, malnutrition, inflammatory bowel disease, colitis, obesity 327 
and type II diabetes [16]. The experimental findings have elaborated that there is a distinct 328 
difference between the gut microbial composition of HT patients and healthy controls. The 329 
results were validated by revealing the dominant bands sequencing of DGGE profile, 330 
pyrosequencing analysis as well as real time PCR. The statistical analysis of α –diversity, 331 
nonparametric Chao1, algorithm ACE, and observed species was significantly elevated in 332 
the diseased group as compared to healthy control, while good’s coverage was significantly 333 
higher in control group. Conversely, no significant distinction was found in diversity index 334 
like Shannon and Simpson, which was aligned with recently reported work[33]. Moreover, 335 
the bacterial community diversity estimation by DGGE profiles and pyrosequencing 336 
analysis was higher in HT patients. This elevation denotes the overgrowth of the gut flora 337 
in patients than in healthy control, although there was raised interpersonal difference that 338 
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corresponds to previous microbial finding in the vagina, gastrointestinal tract and skin [34, 339 
35].  340 
The statistical interpretation of similarity index of gut microbiota in HT patients in DGGE 341 
profiles pattern in intra-groups was found to be higher; this rise clearly demarcated the 342 
intestinal bacterial overgrowth in patients group. The estimation of similarity index 343 
comparison i.e. less in inter- group as compared to intra-group that by previous research 344 
findings[36], demonstrating the dissimilarity of gut microbial composition in HT patients 345 
as compared to control group. Therefore, all these diversity above outcomes illustrate that 346 
there is a significant disparity of gut microbial texture between diseased and control group. 347 
The statistical data represent the important quantitative difference between diseased and 348 
control groups. At the phylum level, Actinobacteria showeda raised level in the diseased 349 
group as compared to control which is consistent with previous work of physiological stress 350 
and gut microbiota [37]. The relative abundance of families Prevotellaceae and 351 
Veillonellaceae was lowered in patients group in contrast to healthy control which is 352 
aligned with previous work[33, 38].Veillonellaceae has beneficial commensal role i.e.very 353 
closely interrelated toClostridium and isinvolved inthe induction of immune T regulatory 354 
cells [39].While Enterobacteriaceae and Alcaligenaceae were higher in the diseased group 355 
in comparison to healthy control.A Higher level of Enterobacteriaceae is aligned with 356 
previous work of type 2 diabetic patients and gut flora [40].However, decreased genera in 357 
the diseased group were Prevotella_9 and Dialister. The diminished Prevotella presence 358 
has been shown in a disease like autism and types1 diabetes with intestinal microbiota  359 
[41, 42], while augmented genera in the diseased group were Escherichia-Shigella and 360 
Parasutterella. The raised level of Escherichia-Shigellais reported in preceding work of 361 
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autism spectrum disorders related to intestinal flora [43], while a higher level of 362 
Parasutterella aligned with preceding findings[44]. 363 
The current meta-analysis on intestinal microbiota linked with obesity and IBD revealed 364 
that percentage between Bacteroidetes to Firmicutes: may not be a steady characteristic 365 
that is distinctive between obese to lean gut flora[45]. Also, the current study findings 366 
demonstrate the raised level of Actinobacteria. It has been documented that Actinobacteria 367 
has the capability to settle in gingival crevices and is responsible for dental plaque 368 
accumulation, also produces the acid that results in infections or cavities [46].Our findings 369 
denoted the decreased values of genus Prevotella;nevertheless, the literature evidence 370 
describes the dominance of Prevotella in agut microbial composition exhibiting the 371 
positive impact on host metabolism[47]. Prevotella prevalence is considered as abeneficial 372 
bacteria in connection with plant based diet, and thus its intestinal flora has linked with 373 
many diseases and inflammatory conditions [48, 49]. The results showed a raised level of 374 
Escherichia-Shigella in HT patients as compared to healthy subjects. It has been 375 
documented that Escherichia-Shigella is Shiga-toxin producing bacteria that can cause 376 
septicemia, hemorrhagic colitis, thrombocytopenia, severe gastrointestinal tract 377 
inflammations in particular ileo-colonic area, spiteful problems of urinary duct channels 378 
and (HUS) hemolytic uremic syndrome.[50]. The current experimental study depicted a 379 
raised level of genus Escherichia-Shigella, in particular, species (E.coli) that might be the 380 
causative gut microbe in HT. Furthermore, ubiquitous Escherichia coli are responsible for 381 
causing the prevalent infections like (UTIs) urinary tract infections and food borne illnesses 382 
[51]. 383 
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The evidence of current work elaborated the relative predominance of phylum, family, 384 
genus as well as species level taxa in stool samples, which also illustrated a clear disparity 385 
between HT patients and normal healthy subjects. Moreover, species level phylotypes with 386 
community comparison also divulged a clear demarcation of intestinal microbial texture 387 
between diseased and control groups [52]. These investigations further unravel the HT role 388 
in physiological intestinal changes that in turn contributes in alteration of the gut microbial 389 
composition. Moreover, these fluctuations in gut microbial configuration may lead to the 390 
complication of diseases[53].  391 
The clinical signs of autoimmune HT manifested with hypothyroidism, goiter along with 392 
circulating antibodies to thyroid antigens. The results of the serum thyroid hormones level 393 
and circulating antibodies, anti-thyroglobulin anti-thyroid peroxidase in both HT and 394 
control, shown in table S3 and table S2 respectively. The findings of HT patientsin table 395 
S3 demonstrate the extremely raised level of aforesaid antibodies in HT as compared to 396 
healthy subjects. The increased level of antibodies in HT patients might change the gut 397 
microbial composition, in particular, the PhylumProteobacteria, family Prevotellaceae 398 
Veillonellaceae, generaPrevotella_9, Dialister,Escherichia-Shigella and E.coli species, 399 
and also broadly affect the gut flora. The current work on gut microbial differences between 400 
HT patients and healthy subjects was found pretty motivating as there was no straight and 401 
direct established relationship between HT and intestinal flora. Therefore, current findings 402 
further elaborate the diversification of gut microbial compositions between HT diseased 403 
and healthy groups. These fluctuations may change the health status of the host even though 404 
disease development is not associated with the intestinal tract [54]. 405 
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The Real time PCR was performed to observe the gut microbial quantitative alterations 406 
[55], the data represent a significant decrease in Bifidobacterium and Lactobacillus in the 407 
diseased group thus aligning with preceding work [56]. The probiotics used in food most 408 
recurrently, generally belong to Bifidobacterium and Lactobacillus genera and encompass 409 
physiological benefits in the body[57]. Bifidobacterium and Lactobacillusare constantly 410 
reduced in colorectal cancer [58]. In addition to that, they also showed anti-obesity, anti-411 
inflammatory and anti-atherogenic influential effects in many studies [59]. Various 412 
lactobacillus strains possess fair antimicrobial behavior to shield the body in opposition to 413 
uropathogens[60].  414 
The current study findings generated from DGGE and pyrosequencing are reliable to 415 
analyze the gut microbiota. However, an experimental technique like PCR-DGGE is a 416 
semi-quantitative procedure; outcomes of bands density evaluation might not narrate the 417 
target abundance of gut flora correctly. [23]. However, pyrosequencing is a more advanced, 418 
sensitive and more reliable method to investigate and analyze the gut microbial ecology 419 
[54]. On the other hand, thePCR-DGGE technique could be used as a basic test to examine 420 
the notable shift of gut microbial community due to inexpensive and less time-421 
consumingprocedure. 422 
5. Conclusion  423 
The current study demonstrates that gut microbial composition is different between HT 424 
patients and the normal control groups. More precisely, there is an important dissimilarity 425 
of gut microbial taxa richness as compared to control group. Furthermore, thelevel of 426 
certain intestinal microbes was either lowered or elevated profusion in HT patients in 427 
comparison to their healthy counterparts. The diversity of bacterial community estimation 428 
25 
 
analysis demonstrates an elevated level of gut flora in HT patients as compared with 429 
controls,which is an indication of bacterial overgrowth in HT patients. Therefore, the 430 
further multicenter approach is obligatory to comprehend the underlying mechanism and 431 
process of intestinal bacterial dysbiosis in Hashimoto’s thyroiditis. 432 
Disclosure 433 
All authors disclose that they do not have any conflict of interest. 434 
Acknowledgement 435 
The author would like to thank Dr. Hui Guo (Department of Endocrinology 1st affiliated 436 
Hospital Xi'an Jiotong University, China) for providing support in sample collection for 437 
this study. 438 
Literature Cited: 439 
[1] S.E. Power, P.W. O'Toole, C. Stanton, R.P. Ross, G.F. Fitzgerald, Intestinal microbiota, diet and 440 
health, British Journal of Nutrition  (2013) 1-16. 441 
[2] C.J. Walsh, C.M. Guinane, P.W. O’Toole, P.D. Cotter, Beneficial modulation of the gut 442 
microbiota, FEBS Letters  (2014). 443 
[3] N. Kamada, G.Y. Chen, N. Inohara, G. Núñez, Control of pathogens and pathobionts by the 444 
gut microbiota, Nature immunology 14(7) (2013) 685-690. 445 
[4] Y. Hiromatsu, H. Satoh, N. Amino, Hashimoto's thyroiditis: history and future outlook, 446 
Hormones 12(1) (2013) 12-8. 447 
[5] D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity, 448 
Endocrine 42(2) (2012) 252-265. 449 
[6] S.H. Golden, K.A. Robinson, I. Saldanha, B. Anton, P.W. Ladenson, Prevalence and Incidence 450 
of Endocrine and Metabolic Disorders in the United States: A Comprehensive Review, Journal of 451 
Clinical Endocrinology & Metabolism 94(6) (2009) 1853. 452 
[7] B. Delemer, J.P. Aubert, P. Nys, F. Landron, S. Bouée, An observational study of the initial 453 
management of hypothyroidism in France: the ORCHIDÉE study, European Journal of 454 
Endocrinology 167(6) (2012) 817-23. 455 
[8] P. Caturegli, A.D. Remigis, N.R. Rose, Hashimoto thyroiditis: Clinical and diagnostic criteria, 456 
Autoimmunity reviews 13(4–5) (2014) 391-397. 457 
[9] W.M. Wiersinga, Smoking and thyroid, Clinical Endocrinology 79(2) (2013) 145-151. 458 
[10] J. Cárdenasroldán, A. Rojasvillarraga, J.M. Anaya, How do autoimmune diseases cluster in 459 
families? A systematic review and meta-analysis, Bmc Medicine 11(1) (2013) 73. 460 
[11] W. Teng, Z. Shan, X. Teng, H. Guan, Y. Li, D. Teng, Y. Jin, X. Yu, C. Fan, W. Chong, Effect of 461 
iodine intake on thyroid diseases in China, The New England journal of medicine 354(26) (2006) 462 
2783-93. 463 
26 
 
[12] X. Teng, Z. Shan, Y. Chen, Y. Lai, J. Yu, L. Shan, X. Bai, Y. Li, N. Li, Z. Li, More than adequate 464 
iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-465 
sectional study based on two Chinese communities with different iodine intake levels, European 466 
Journal of Endocrinology 164(6) (2011) 943. 467 
[13] U. Vyas, N. Ranganathan, Probiotics, prebiotics, and synbiotics: gut and beyond, 468 
Gastroenterology Research & Practice 2012(11) (2012) 872716. 469 
[14] L. Xiao, F.S. Muhali, T.T. Cai, R.H. Song, R. Hu, X.H. Shi, W.J. Jiang, D.F. Li, S.T. He, J. Xu, 470 
Association of single-nucleotide polymorphisms in the STAT3 gene with autoimmune thyroid 471 
disease in Chinese individuals, Functional & Integrative Genomics 13(4) (2013) 455-461. 472 
[15] F. Guarner, J.R. Malagelada, Gut flora in health and disease, Lancet 361(9356) (2003) 512-473 
519. 474 
[16] A. Khoruts, J. Dicksved, J.K. Jansson, M.J. Sadowsky, Changes in the composition of the 475 
human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated 476 
diarrhea, Journal of clinical gastroenterology 44(5) (2010) 354-360. 477 
[17] K. Mori, Y. Nakagawa, H. Ozaki, Does the gut microbiota trigger Hashimoto's thyroiditis?, 478 
Discov Med 14(78) (2012) 321-6. 479 
[18] A.J. Giannini, The Biological foundations of clinical psychiatry, Medical Examination Pub. 480 
Co.1986. 481 
[19] P.D. Scanlan, F. Shanahan, C. O'Mahony, J.R. Marchesi, Culture-independent analyses of 482 
temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's 483 
disease, Journal of clinical microbiology 44(11) (2006) 3980-8. 484 
[20] G. Muyzer, E.C. De Waal, A.G. Uitterlinden, Profiling of complex microbial populations by 485 
denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes 486 
coding for 16S rRNA, Applied and environmental microbiology 59(3) (1993) 695-700. 487 
[21] Z. Ling, J. Kong, F. Liu, H. Zhu, X. Chen, Y. Wang, L. Li, K.E. Nelson, Y. Xia, C. Xiang, Molecular 488 
analysis of the diversity of vaginal microbiota associated with bacterial vaginosis, BMC genomics 489 
11(1) (2010) 488. 490 
[22] G.P. Gafan, V.S. Lucas, G.J. Roberts, A. Petrie, M. Wilson, D.A. Spratt, Statistical analyses of 491 
complex denaturing gradient gel electrophoresis profiles, Journal of clinical microbiology 43(8) 492 
(2005) 3971-3978. 493 
[23] R.G. Ledder, P. Gilbert, S.A. Huws, L. Aarons, M.P. Ashley, P.S. Hull, A.J. McBain, Molecular 494 
analysis of the subgingival microbiota in health and disease, Applied and Environmental 495 
Microbiology 73(2) (2007) 516-523. 496 
[24] N. Fromin, J. Hamelin, S. Tarnawski, D. Roesti, K. Jourdain‐Miserez, N. Forestier, S. 497 
Teyssier‐Cuvelle, F. Gillet, M. Aragno, P. Rossi, Statistical analysis of denaturing gel 498 
electrophoresis (DGE) fingerprinting patterns, Environmental Microbiology 4(11) (2002) 634-499 
643. 500 
[25] S.J. Green, M.B. Leigh, J.D. Neufeld, Denaturing gradient gel electrophoresis (DGGE) for 501 
microbial community analysis, Handbook of hydrocarbon and lipid microbiology, Springer2010, 502 
pp. 4137-4158. 503 
[26] T. Matsuki, K. Watanabe, J. Fujimoto, T. Takada, R. Tanaka, Use of 16S rRNA gene-targeted 504 
group-specific primers for real-time PCR analysis of predominant bacteria in human feces, 505 
Applied and Environmental Microbiology 70(12) (2004) 7220-7228. 506 
[27] J.A. Peiffer, A. Spor, O. Koren, Z. Jin, S.G. Tringe, J.L. Dangl, E.S. Buckler, R.E. Ley, Diversity 507 
and heritability of the maize rhizosphere microbiome under field conditions, Proceedings of the 508 
National Academy of Sciences of the United States of America 110(16) (2013) 6548-53. 509 
[28] J.G. Caporaso, J. Kuczynski, J. Stombaugh, K. Bittinger, F.D. Bushman, E.K. Costello, N. Fierer, 510 
A.G. Pena, J.K. Goodrich, J.I. Gordon, G.A. Huttley, S.T. Kelley, D. Knights, J.E. Koenig, R.E. Ley, 511 
27 
 
C.A. Lozupone, D. McDonald, B.D. Muegge, M. Pirrung, J. Reeder, J.R. Sevinsky, P.J. Turnbaugh, 512 
W.A. Walters, J. Widmann, T. Yatsunenko, J. Zaneveld, R. Knight, QIIME allows analysis of high-513 
throughput community sequencing data, Nat Methods 7(5) (2010) 335-6. 514 
[29] T. Magoč, S.L. Salzberg, FLASH: fast length adjustment of short reads to improve genome 515 
assemblies, Bioinformatics 27(21) (2011) 2957-63. 516 
[30] Q. Wang, G.M. Garrity, J.M. Tiedje, J.R. Cole, Naïve Bayesian Classifier for Rapid Assignment 517 
of rRNA Sequences into the New Bacterial Taxonomy, Applied and Environmental Microbiology 518 
73(16) (2007) 5261-5267. 519 
[31] D.H. Huson, S. Mitra, H.J. Ruscheweyh, N. Weber, S.C. Schuster, Integrative analysis of 520 
environmental sequences using MEGAN4, Genome Research 21(9) (2011) 1552. 521 
[32] F. Guarner, J.-R. Malagelada, Gut flora in health and disease, The Lancet 361(9356) (2003) 522 
512-519. 523 
[33] J. Chen, N. Chia, K.R. Kalari, J.Z. Yao, M. Novotna, M.M.P. Soldan, D.H. Luckey, E.V. Marietta, 524 
P.R. Jeraldo, X. Chen, Multiple sclerosis patients have a distinct gut microbiota compared to 525 
healthy controls, Scientific Reports 6 (2016) 28484. 526 
[34] R. Hummelen, A.D. Fernandes, J.M. Macklaim, R.J. Dickson, J. Changalucha, G.B. Gloor, G. 527 
Reid, Deep Sequencing of the Vaginal Microbiota of Women with HIV, PloS one 5(8) (2010) 528 
e12078. 529 
[35] Z. Ling, J. Kong, P. Jia, C. Wei, Y. Wang, Z. Pan, W. Huang, L. Li, H. Chen, C. Xiang, Analysis of 530 
oral microbiota in children with dental caries by PCR-DGGE and barcoded pyrosequencing, 531 
Microbial Ecology 60(3) (2010) 677-690. 532 
[36] X. Wu, C. Ma, L. Han, M. Nawaz, F. Gao, X. Zhang, P. Yu, C.a. Zhao, L. Li, A. Zhou, Molecular 533 
characterisation of the faecal microbiota in patients with type II diabetes, Current microbiology 534 
61(1) (2010) 69-78. 535 
[37] J.P. Karl, L.M. Margolis, E.H. Madslien, N.E. Murphy, J.W. Castellani, Y. Gundersen, A.V. 536 
Hoke, M.W. Levangie, R. Kumar, N. Chakraborty, A. Gautam, R. Hammamieh, S. Martini, S.J. 537 
Montain, S.M. Pasiakos, Changes in intestinal microbiota composition and metabolism coincide 538 
with increased intestinal permeability in young adults under prolonged physiologic stress, 539 
American journal of physiology. Gastrointestinal and liver physiology  (2017) ajpgi 00066 2017. 540 
[38] M. Zhang, M. Zheng, Z. Wu, M. Guan, S. Liu, W. Zhao, J. Cheng, Alteration of gut microbial 541 
community after N,N-Dimethylformamide exposure, The Journal of toxicological sciences 42(2) 542 
(2017) 241-250. 543 
[39] K. Atarashi, T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, Y. Momose, G. Cheng, S. 544 
Yamasaki, T. Saito, Y. Ohba, Induction of Colonic Regulatory T Cells by Indigenous Clostridium 545 
Species, Science 331(6015) (2011) 337. 546 
[40] Y. Wang, X. Luo, X. Mao, Y. Tao, X. Ran, H. Zhao, J. Xiong, L. Li, Gut microbiome analysis of 547 
type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks, PloS 548 
one 12(3) (2017) e0172774. 549 
[41] D.W. Kang, G.P. Jin, Z.E. Ilhan, G. Wallstrom, J. Labaer, J.B. Adams, R. Krajmalnikbrown, 550 
Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic 551 
Children, PloS one 8(7) (2013) e68322. 552 
[42] M. Murri, I. Leiva, J.M. Gomez-Zumaquero, F.J. Tinahones, F. Cardona, F. Soriguer, M.I. 553 
Queipo-Ortuño, Gut microbiota in children with type 1 diabetes differs from that in healthy 554 
children: a case-control study, BMC Medicine 11(1) (2013) 46. 555 
[43] F. Strati, D. Cavalieri, D. Albanese, C. De Felice, C. Donati, J. Hayek, O. Jousson, S. Leoncini, 556 
D. Renzi, A. Calabro, C. De Filippo, New evidences on the altered gut microbiota in autism 557 
spectrum disorders, Microbiome 5(1) (2017) 24. 558 
28 
 
[44] E.E. Noble, T.M. Hsu, R.B. Jones, A.A. Fodor, M.I. Goran, S.E. Kanoski, Early-Life Sugar 559 
Consumption Affects the Rat Microbiome Independently of Obesity, The Journal of nutrition 560 
147(1) (2017) 20-28. 561 
[45] W.A. Walters, Z. Xu, R. Knight, Meta-analyses of human gut microbes associated with 562 
obesity and IBD, FEBS letters 588(22) (2014) 4223. 563 
[46] G. Reynolds-Campbell, A. Nicholson, C.-A. Thoms-Rodriguez, Oral Bacterial Infections : 564 
Diagnosis and Management, Dental Clinics of North America 61 (2017) 305–318. 565 
[47] P. Kovatchevadatchary, A. Nilsson, R. Akrami, Y.S. Lee, V.F. De, T. Arora, A. Hallen, E. 566 
Martens, I. Björck, F. Bäckhed, Dietary Fiber-Induced Improvement in Glucose Metabolism Is 567 
Associated with Increased Abundance of Prevotella, Cell Metabolism 22(6) (2015) 971-982. 568 
[48] J. Scher, [Original String]: Scher, J.U. et al. Expansion of intestinal Prevotella copri correlates 569 
with enhanced susceptibility to arthritis. eLife 2, e01202 (2013), Elife Sciences 2(1629) (2010) 570 
e01202. 571 
[49] S.M. Dillon, E.J. Lee, C.V. Kotter, G.L. Austin, S. Gianella, B. Siewe, D.M. Smith, A.L. Landay, 572 
M.C. Mcmanus, C.E. Robertson, Gut Dendritic Cell Activation Links an Altered Colonic 573 
Microbiome to Mucosal and Systemic T Cell Activation in Untreated HIV-1 infection, Mucosal 574 
Immunology 9(1) (2015) 24-37. 575 
[50] J. Amani, A. Ahmadpour, A.A. Imani Fooladi, S. Nazarian, Detection of E. coli O157:H7 and 576 
Shigella dysenteriae toxins in clinical samples by PCR-ELISA, The Brazilian journal of infectious 577 
diseases : an official publication of the Brazilian Society of Infectious Diseases 19(3) (2015) 278-578 
84. 579 
[51] M.A. Mulvey, J.D. Schilling, J.J. Martinez, S.J. Hultgren, Bad bugs and beleaguered bladders: 580 
Interplay between uropathogenic Escherichia coli and innate host defenses, Proceedings of the 581 
National Academy of Sciences of the United States of America 97(16) (2000) 8829-8835. 582 
[52] C. Manichanh, E. Varela, C. Martinez, M. Antolin, M. Llopis, J. Doré, J. Giralt, F. Guarner, J.R. 583 
Malagelada, The gut microbiota predispose to the pathophysiology of acute postradiotherapy 584 
diarrhea, American Journal of Gastroenterology 103(7) (2008) 1754-1761. 585 
[53] J. Qin, R. Li, J. Raes, M. Arumugam, K.S. Burgdorf, C. Manichanh, T. Nielsen, N. Pons, F. 586 
Levenez, T. Yamada, A human gut microbial gene catalogue established by metagenomic 587 
sequencing, Nature 464(7285) (2010) 59-65. 588 
[54] Y.D. Nam, H.J. Kim, J.G. Seo, S.W. Kang, J.W. Bae, Impact of Pelvic Radiotherapy on Gut 589 
Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing, 8(12) (2013) 590 
e82659. 591 
[55] S.R. Lyons, A.L. Griffen, E.J. Leys, Quantitative real-time PCR forPorphyromonas gingivalis 592 
and total bacteria, Journal of clinical microbiology 38(6) (2000) 2362-2365. 593 
[56] L. Zhou, X. Li, A. Ahmed, D. Wu, L. Liu, J. Qiu, Y. Yan, M. Jin, Y. Xin, Gut microbe analysis 594 
between hyperthyroid and healthy individuals, Current microbiology 69(5) (2014) 675-680. 595 
[57] M.J. Butel, Probiotics, gut microbiota and health, Medecine et maladies infectieuses 44(1) 596 
(2014) 1-8. 597 
[58] M. Borges-Canha, J.P. Portela-Cidade, M. Dinis-Ribeiro, A.F. Leite-Moreira, P. Pimentel-598 
Nunes, Role of colonic microbiota in colorectal carcinogenesis: a systematic review, Revista 599 
Española de Enfermedades Digestivas 107(11) (2015) 659-671. 600 
[59] E. Nova, F. Perez de Heredia, S. Gomez-Martinez, A. Marcos, The Role of Probiotics on the 601 
Microbiota: Effect on Obesity, Nutrition in clinical practice : official publication of the American 602 
Society for Parenteral and Enteral Nutrition  (2016). 603 
[60] Y.H. Shim, S.J. Lee, J.W. Lee, Antimicrobial activities of Lactobacillus Strains against 604 
Uropathogens, Pediatrics international : official journal of the Japan Pediatric Society  (2016). 605 
29 
 
 606 
